The complexity of developing and manufacturing GMP peptides can often be a significant barrier to developers. Fortunately, Contract Development and Manufacturing Organizations (CDMOs) have emerged as valuable collaborators in this sector. With specialized expertise and cutting-edge facilities, CDMOs can accelerate the development process, enabling